Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
Pregnancy in women with end-stage renal disease (ESRD) is exceptionally rare due to impaired fertility, anovulation, and hormonal imbalance. When it occurs, it is associated with increased maternal and fetal risks including pre-eclampsia, fluid overload, uremia, and poor placental perfusion, often leading to miscarriage, fetal growth restriction (FGR), or preterm birth. Recent advancements in renal replacement therapy, nutrition, and multidisciplinary perinatal care have improved pregnancy outcomes in this population. This report presents a rare case of successful pregnancy outcome in a woman with ESRD managed with intensive hemodialysis and other supportive managements.
A 28-year-old woman, incidentally diagnosed with pregnancy at 4 months’ gestation, was found to have serum creatinine 11 mg/dL and hemoglobin 6 g/dL, confirming ESRD. She was counseled regarding high maternal and fetal risks and advice to terminate pregnancy but she opted to continue the pregnancy. The patient was referred to a tertiary care center where a multidisciplinary team involving nephrology, obstetrics, nutrition, and neonatology provided coordinated management. Daily hemodialysis (six sessions per week) was initiated to maintain pre-dialysis blood urea below 50 mg/dL. Blood pressure, electrolytes, hemoglobin, and nutritional status were closely monitored. Erythropoietin, iron supplementation, and antihypertensive therapy were administered as required. Serial ultrasonography and Doppler assessments were performed to monitor fetal growth and well-being.
Despite optimal management, fetal growth restriction developed in the third trimester. At 34 weeks’ gestation, spontaneous preterm labor occurred. Hemodialysis was performed prior to delivery to stabilize maternal biochemical status. The patient delivered vaginally a live female infant weighing 1500 grams. Postpartum dialysis was continued to maintain metabolic balance. Both mother and baby had an uneventful recovery with no major complications.
This case highlights that successful pregnancy is achievable in women with ESRD through intensive hemodialysis, strict metabolic control, and multidisciplinary collaboration. Early referral to specialized centers, individualized management, and patient motivation are essential for optimizing outcomes. With commitment and coordinated care, even pregnancies complicated by ESRD can conclude in favorable maternal and neonatal results.
